Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (56)
Guidance programme
(
1 selected
)
Guidance programme
Clinical guidelines (23)
Diagnostics guidance (3)
Highly specialised technologies guidance (1)
Interventional procedures guidance (22)
Medical technologies guidance (2)
Medicines practice guidelines (3)
NICE guidelines (34)
Public health guidelines (7)
Social care guidelines (13)
Technology appraisal guidance (56)
Apply filters
Showing 41 to 50 of 56
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2016 and 30/4/2017
Remove Last updated date between 1/4/2016 and 30/4/2017 filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Degarelix for treating advanced hormone-dependent prostate cancer
TA404
24 August 2016
24 August 2016
Trifluridine–tipiracil for previously treated metastatic colorectal cancer
TA405
24 August 2016
24 August 2016
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel
TA391
25 May 2016
24 August 2016
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen
TA259
27 June 2012
27 July 2016
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation
TA398
27 July 2016
27 July 2016
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts
TA399
27 July 2016
27 July 2016
Nivolumab in combination with ipilimumab for treating advanced melanoma
TA400
27 July 2016
27 July 2016
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
TA387
27 April 2016
27 July 2016
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
TA393
22 June 2016
22 June 2016
Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
TA394
22 June 2016
22 June 2016
Previous page
1
3
4
Current page
5
6
Page
5
of
6
Next page
Results per page
10
25
50
All
Back to top